These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Application of metrizamide in the radiographic evaluation of the neurologically diseased patient. Maravilla KR; Neuwelt EA; Diehl JT Neurosurgery; 1979 Sep; 5(3):389-406. PubMed ID: 315524 [TBL] [Abstract][Full Text] [Related]
3. Comparison between EEG and observation of rabbit behaviour in evaluation of subarachnoid neurotoxicity of metrizamide. Maly P; Elmqvist D; Almén T; Golman K Acta Radiol Diagn (Stockh); 1986; 27(2):235-40. PubMed ID: 3716871 [TBL] [Abstract][Full Text] [Related]
4. Use of pentobarbital sodium to reduce seizures in dogs after cervical myelography with metrizamide. Gray PR; Indrieri RJ; Lowrie CT J Am Vet Med Assoc; 1987 Jun; 190(11):1422-4. PubMed ID: 3610751 [TBL] [Abstract][Full Text] [Related]
5. Irreversible neurologic complications of metrizamide myelography. Meador K; Hamilton WJ; El Gammal TA; Demetropoulos KC; Nichols FT Neurology; 1984 Jun; 34(6):817-21. PubMed ID: 6539448 [TBL] [Abstract][Full Text] [Related]
6. Cat optic nerve imaging with metrizamide. Davis JP; Haughton VM; Harris GJ; Eldevik OP; Gager WE Invest Ophthalmol Vis Sci; 1979 Mar; 18(3):273-7. PubMed ID: 422333 [TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of metrizamide for neuroradiology in chilren. Swick HM; Sty JR; Haughton VM Ann Neurol; 1978 May; 3(5):409-15. PubMed ID: 310277 [TBL] [Abstract][Full Text] [Related]
9. Metrizamide myelography risk factors: a pseudopsychiatric case presentation. Blair R; Lippmann S J Clin Psychiatry; 1985 Oct; 46(10):439-40. PubMed ID: 4044535 [TBL] [Abstract][Full Text] [Related]
10. [Metrizamide - a modern nonionizing contrast medium. Diagnostics of the central nervous system with emphasis on myeloradiculography]. Ledić S; Lisanin L; Citić R; Dordević D Vojnosanit Pregl; 1980; 37(6):442-50. PubMed ID: 7210584 [No Abstract] [Full Text] [Related]
12. Influence of anesthetic regimen on the frequency of seizures after cervical myelography in the dog. Gray PR; Indrieri RJ; Lippert AC J Am Vet Med Assoc; 1987 Mar; 190(5):527-30. PubMed ID: 3558089 [TBL] [Abstract][Full Text] [Related]
13. Neurotoxicity of novel water-soluble contrast media for intrathecal application. Gonsette RE; Brucher JM Invest Radiol; 1980; 15(6 Suppl):S254-9. PubMed ID: 6894139 [TBL] [Abstract][Full Text] [Related]
14. Malignant hyperthermia-like syndrome associated with metrizamide myelography. Ong RO; Rosenberg H Anesth Analg; 1989 Jun; 68(6):795-7. PubMed ID: 2735545 [No Abstract] [Full Text] [Related]
15. Anaesthesia and central nervous system disease in small animals. Part I: General considerations. Court MH; Dodman NH; Norman WM; Seeler DC Br Vet J; 1990; 146(4):285-95. PubMed ID: 2204464 [No Abstract] [Full Text] [Related]
19. Effect of intravenous administration of dextrose or lactated Ringer's solution on seizure development in dogs after cervical myelography with metrizamide. Gray PR; Lowrie CT; Wetmore LA Am J Vet Res; 1987 Nov; 48(11):1600-2. PubMed ID: 3434904 [TBL] [Abstract][Full Text] [Related]
20. Metrizamide: a review with emphasis on drug interactions. Hanus PM Am J Hosp Pharm; 1980 Apr; 37(4):510-3. PubMed ID: 6103672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]